A new trading day began on Tuesday, with NRX Pharmaceuticals Inc (NASDAQ: NRXP) stock price down -11.97% from the previous day of trading, before settling in for the closing price of $4.01. NRXP’s price has ranged from $1.10 to $7.33 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 53.58%. With a float of $9.20 million, this company’s outstanding shares have now reached $11.37 million.
In terms of profitability, gross margin is 62.5%, operating margin of -255950.0%, and the pretax margin is -254750.0%.
NRX Pharmaceuticals Inc (NRXP) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of NRX Pharmaceuticals Inc is 23.89%, while institutional ownership is 5.91%. The most recent insider transaction that took place on Dec 17 ’24, was worth 46,800. In this transaction Chairman and Chief Scientist of this company bought 40,000 shares at a rate of $1.17, taking the stock ownership to the 84,634 shares.
NRX Pharmaceuticals Inc (NRXP) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.58% per share during the next fiscal year.
NRX Pharmaceuticals Inc (NASDAQ: NRXP) Trading Performance Indicators
Here are NRX Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.15, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach 0.32 in one year’s time.
Technical Analysis of NRX Pharmaceuticals Inc (NRXP)
Analysing the last 5-days average volume posted by the [NRX Pharmaceuticals Inc, NRXP], we can find that recorded value of 1.03 million was lower than the volume posted last year of 3.17 million. As of the previous 9 days, the stock’s Stochastic %D was 30.42%. Additionally, its Average True Range was 0.69.
During the past 100 days, NRX Pharmaceuticals Inc’s (NRXP) raw stochastic average was set at 49.49%, which indicates a significant increase from 45.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 293.97% in the past 14 days, which was higher than the 138.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.99, while its 200-day Moving Average is $2.36. Now, the first resistance to watch is $3.90. This is followed by the second major resistance level at $4.26. The third major resistance level sits at $4.51. If the price goes on to break the first support level at $3.29, it is likely to go to the next support level at $3.04. Now, if the price goes above the second support level, the third support stands at $2.68.
NRX Pharmaceuticals Inc (NASDAQ: NRXP) Key Stats
With a market capitalization of 42.69 million, the company has a total of 12,094K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,150 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,620 K.
